asa glp-1 agonists How should we approach patients on agonists? Check out this excellent editorial from Dr. Girish Joshi, "Clarifying the Guidelines and Decoding the Enigma: Strategies for Anesthetic Management of Patients on Glucagon-Like Researchers find GLP-1 medications safe

The clinical trial data (OASIS 4, NEJM 2025) showed an average body weight loss of 16.6% at 64 weeks

An optimal range might be ~10-35 mcg/ml

They pursue additional years of training, learning to identify and treat the root causes of illness, such as gut dysfunction, inflammation, nutrient deficiencies, hormone imbalances, toxins, and chronic stress- rather than simply managing symptoms with medication

GLUCOSAMINE L G

doi: 10.1210/endo.142.5.8128 50 BnemannMGerhardsteinBLGaoTHoseyMM

A non-linear dose-response relationship was observed between L-Carnitine supplementation and weight loss, suggesting that 2000 mg of L-Carnitine daily provides the maximum effect in adults